JiangXi Tianxin Pharm Co Ltd (603235) — Cash Flow Quality Index

Latest as of December 2025: 1.06x

JiangXi Tianxin Pharm Co Ltd (603235) has a Cash Flow Quality Index of 1.06x as of December 2025. Operating cash flow of CN¥629.36 Million exceeds net income of CN¥591.58 Million, indicating high earnings quality where cash backs reported profits. Explore JiangXi Tianxin Pharm Co Ltd (603235) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

1.06x
Operating CF / Net Income

Operating Cash Flow

CN¥629.36 Million
CNY

Net Income

CN¥591.58 Million
CNY

Data as of

Dec 2025
Most recent filing

JiangXi Tianxin Pharm Co Ltd Cash Flow Quality Index (2020–2025)

Historical Cash Flow Quality Index for JiangXi Tianxin Pharm Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check JiangXi Tianxin Pharm Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for JiangXi Tianxin Pharm Co Ltd (2020–2025)

Year-by-year earnings quality comparison for JiangXi Tianxin Pharm Co Ltd. For live market cap and the full company financial profile, see JiangXi Tianxin Pharm Co Ltd stock valuation.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2025 1.06x CN¥629.36 Million CN¥591.58 Million ▲ +38.7%
2024 0.77x CN¥499.66 Million CN¥651.22 Million ▼ -49.9%
2023 1.53x CN¥729.21 Million CN¥475.85 Million ▲ +57.2%
2022 0.98x CN¥606.61 Million CN¥622.12 Million ▼ -11.4%
2021 1.10x CN¥818.63 Million CN¥743.89 Million ▼ -15.2%
2020 1.30x CN¥1.16 Billion CN¥897.03 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.